Conditional modulation of membrane protein expression in cultured cells mediated by prion protein recognition of short phosphorothioate oligodeoxynucleotides

J Biol Chem. 2011 Mar 4;286(9):6911-7. doi: 10.1074/jbc.M110.194662. Epub 2010 Dec 14.

Abstract

We demonstrate that the levels of native as well as transfected prion protein (PrP) are lowered in various cell lines exposed to phosphorothioate oligodeoxynucleotides (PS-DNA) and can be rapidly reverted to their normal amounts by removal of PS-DNA. This transient modulation was independent of the glycosylation state of PrP, and in addition, all three PrP glycoforms were susceptible to PS-DNA treatment. Deletion of the N-terminal domain (amino acids 23-99), but not of the other domains of PrP, abrogated its PS-DNA-mediated down-regulation. PrP versions localized in the mitochondria, cytoplasm, or nucleus were not modulated by PS-DNA, indicating that PrP surface exposure is required for executing this effect. Proteins that in their native forms were not responsive to PS-DNA, such as thymocyte antigen 1 (Thy1), Doppel protein (Dpl), green fluorescent protein (GFP), and cyan fluorescent protein (CFP), became susceptible to PS-DNA-mediated down-regulation following introduction of the N terminus of PrP into their sequence. These observations demonstrate the essential role of the N-terminal domain for promoting oligonucleotide-mediated reduction of the PrP level and suggest that transient treatment of cultured cells with PS-DNA may provide a general method for targeted modulation of the levels of desired surface proteins in a conditional and reversible manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cell Line, Tumor
  • Cell Membrane / metabolism
  • Cricetinae
  • Cricetulus
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Glycosylation
  • Mice
  • Neuroblastoma
  • Phosphorothioate Oligonucleotides / pharmacology*
  • PrPC Proteins / chemistry
  • PrPC Proteins / genetics
  • PrPC Proteins / metabolism*
  • PrPSc Proteins / chemistry
  • PrPSc Proteins / genetics
  • PrPSc Proteins / metabolism*
  • Prion Diseases / metabolism*
  • Prion Diseases / therapy
  • Protein Structure, Tertiary
  • RNA, Small Interfering
  • Transfection
  • Tunicamycin / pharmacology

Substances

  • Phosphorothioate Oligonucleotides
  • PrPC Proteins
  • PrPSc Proteins
  • RNA, Small Interfering
  • Tunicamycin